” Though the Ricaurte Tale was unfolding, MAPS ultimately acquired FDA signal-off over a protocol for human trials of MDMA as being a cure for PTSD, but only after it obtained a $one million insurance coverage to indemnify the evaluation board. In the nineties, the FDA accredited the very f